Products Affected - Description
Reason for the Shortage
- Hospira had metronidazole injection on back order due to manufacturing delays.
- BBraun was allocating metronidazole injection due to increased demand for the product.
Metronidazole injection, Baxter
500 mg/100 mL, 24 count (NDC 00338-1055-48)
Metronidazole injection, BBraun
500 mg/100 mL, 24 count (NDC 00264-5535-32)
Metronidazole Injection, Claris
500 mg/100 mL, 24 count (NDC 36000-0001-24)
Metronidazole injection, Hospira
500 mg/100 mL, 24 count (NDC 00409-7811-24)
500 mg/100 mL, 80 count (quad pack) (NDC 00409-7811-37)
Estimated Resupply Dates
All presentations are currently available.
Hospira’s metronidazole quad pack bags (NDC 00409-7811-37) are packaged in an overwrap. Use these metronidazole quad pack bags within 7 days after the overwrap is removed and continue to protect the bags from light.
June 8, May 8, February 27, January 29, 2015; November 5, October 3, September 5, August 1, June 3, 5, and 24, May 1, 9, and 12, 2014, University of Utah, Drug Information Service. Copyright 2015, Drug Information Service, University of Utah, Salt Lake City, UT.
This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins